Navigation Links
Medisafe 1 Technologies Corp Notify Shareholders on FINRA's Approval of the 5-1 Stock Dividend
Date:9/16/2010

eptember 17 2010 and Payable Date on September 20 2010

JERUSALEM, September 16, 2010 /PRNewswire-FirstCall/ -- Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, will be issuing and completing a forward stock split of 5-1 in the form of a stock dividend on its common shares.

The stock dividend has been approved by FINRA and will be paid on September 20 2010 to the shareholders of record on September 17 2010.When the stock dividend becomes effective, each shareholder who holds one restricted stock will receive an additional 4 shares of restricted stock and each shareholder who holds one unrestricted stock will receive an additional 4 shares of unrestricted stock. Medisafe 1 Technologies currently has 10,000,000 shares outstanding. The forward stock split in the form of the issuance of the dividend will increase the total shares outstanding to 50,000,000. Medisafe 1 expects the Board's decision will improve liquidity and trading volume in the Company's stock.

About Medisafe 1 Technologies

Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Medisafe 1 Technologies Corp., and its technologies. In evaluating such statements, pr
'/>"/>

SOURCE Medisafe 1 Technologies Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Medisafe 1 Technologies Granted Eligibility Status by the Depository Trust Company
2. Medisafe 1 Technologies Finalises Contract to Develop Prototype of the Worlds First Ever Medicinal Syringe-Locking Device
3. Medisafe 1 Technologies Clarifies the PR Issued on September 1 for the Stock Dividend, as a Forward Split of 5-1 in the Form of a Stock Dividend
4. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
5. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
6. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
7. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
8. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
9. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
10. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
11. Senesco Technologies Initiates Preclinical Studies for Cancer Target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ), ... sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine ... announced the business and development progress at its Jiangchuan ... the September 2014 JCM application (No. 51268) for the ...
(Date:1/22/2015)... Jan. 22, 2015  BiOptix is pleased to announce the ... President of Chemistry and Biochemistry. Scott joins the company after ... and Amgen throughout the course of his nearly 20 ... "Scott is a nationally recognized thought leader in the ...
(Date:1/22/2015)... (NYSE: RMD ) today announced results for its ... $423.0 million, a 10 percent increase compared to the quarter ... constant currency basis). Net income was $91.2 million, an increase ... 2013. Diluted earnings per share for the quarter were $0.64, ...
Breaking Medicine Technology:TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11
... 14, 2010 Illegal online drug sellers have provided ... Internet without a valid prescription, recent research has found. ... or 1 in 6 Americans, exposing them ... The proliferation of illegal online drug sellers offering medication ...
... UBM Canon today announced medical manufacturing event ... utilizing respectively its long established MEDTEC and Medical Design ... MEDTEC India Conference & Exhibition will debut ... international suppliers. The event will deliver the latest in ...
Cached Medicine Technology:36 Million Americans have Bought Medications Online Without a Doctor's Prescription 236 Million Americans have Bought Medications Online Without a Doctor's Prescription 336 Million Americans have Bought Medications Online Without a Doctor's Prescription 4UBM Canon Launches Medical Manufacturing Events in India and Brazil 2
(Date:1/22/2015)... (PRWEB) January 22, 2015 The Incredible Bulk ... Ben Pakulski to increase lean muscle by up to 30lbs ... caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative ... it is a step-by-step, scientific diet formula that allows the ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... ( http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District ... against C.R. Bard, Inc. in that proceeding’s first bellwether trial. ... defense request for a new trial after finding that C.R. ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining ... policy . , Auto insurance quotes help many drivers ... longer necessary to call an agent or visit an agency ... a single website: http://autocarinsurancebest.com/ . , Every business who ...
(Date:1/22/2015)... 22, 2015 A study recently ... flagship journal Medicine & Science in Sports & ... may help reduce gastrointestinal (GI) problems associated with ... Participants in the double-blind, placebo-controlled study took 10 ...
(Date:1/22/2015)... Four years since the release of their debut recording Love ... of Avasa & Matthew Love – the duo are pleased to ... through White Swan Records on February 24, 2015. , THE ROAD ... available to all of us to walk out of the mire ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
... Ore. Oregon Health & Science University Cancer Institute ... SGX393 is effective against Gleevec-resistant chronic myeloid leukemia (CML). ... week of March 24th in the Proceedings of the ... identified by OHSU Cancer Institute Director Brian Druker, M.D., ...
... March 24 Select Medical Corporation,("Select") today announced ... 31, 2007., For the fourth quarter ended ... $518.0 million compared to $445.7 million for the ... to $41.7,million compared to $59.1 million for the ...
... studies shows that white women who are obese are less ... for breast and cervical cancer, according to researchers at the ... Health. , The trend was not seen as consistently among ... examined black women separately. , Obesity is increasing, and so ...
... kids, lifetime risk , , MONDAY, March 24 (HealthDay News) ... parents, high blood pressure and the chances their children ... , A family history of hypertension is well-established as ... to 65 percent of high blood pressure is inherited. ...
... Complimentary Continuing Education Lecture Series for Healthcare ... ... are the,most common and most malignant type of glioma. Healthcare professionals,face ... and mean length of survival in patients is less than,one year., ...
... March 24 /PRNewswire-FirstCall/ - Cardiome Pharma Corp.,(NASDAQ: CRME/TSX: ... 2007,financial results on the morning of Wednesday, March ... webcast at 9:00am Eastern (6:00am,Pacific) on that day ... conference call, please dial 416-641-6117 or,866-299-6655. There will ...
Cached Medicine News:Health News:OHSU Cancer Institute researchers identify new approach to help control drug resistance in leukemia 2Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2007 2Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2007 3Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2007 4Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2007 5Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2007 6Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2007 7Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2007 8Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2007 9Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2007 10Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2007 11Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2007 12Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2007 13Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2007 14Health News:Obesity may keep some women from getting screened for breast, cervical cancer 2Health News:High Blood Pressure Runs in Families 2Health News:High Blood Pressure Runs in Families 3Health News:Adult Glioblastoma: Strategies, Challenges, and Opportunities 2Health News:Cardiome To Release 2007 Results 2Health News:Cardiome To Release 2007 Results 3Health News:Cardiome To Release 2007 Results 4
Townsend is a endocervical stainless-steel curette with round tapered tip....
Available in 5, 8 and 12 mm bite, with and without teeth....
...
...
Medicine Products: